(BPMC) Blueprint Medicines complete technical analysis [charts+indicators] | Buy/Sell Blueprint Medicines | (BPMC) share price targets
Complete technical analysis of Blueprint Medicines (BPMC) by charts plus indicators, forecast predictions and share price targets for Blueprint Medicines (BPMC)
Blueprint Medicines trades in USA in Health Care sector.
Showing technical analysis as on 2024-05-23 View latest technical analysis
10 day averaged volume of Blueprint Medicines is 477245
Date | Daily Closing Price | Open | High | Low | Volume |
23 Thu May 2024 | 102.39 | 103.49 | 105.38 | 101.21 | 1.155 times |
22 Wed May 2024 | 102.71 | 103.07 | 104.15 | 101.42 | 0.809 times |
21 Tue May 2024 | 103.63 | 103.48 | 104.78 | 101.49 | 0.887 times |
20 Mon May 2024 | 104.26 | 104.87 | 105.64 | 103.69 | 0.969 times |
17 Fri May 2024 | 104.96 | 107.00 | 107.17 | 103.23 | 0.871 times |
16 Thu May 2024 | 106.64 | 106.66 | 107.69 | 105.81 | 0.841 times |
15 Wed May 2024 | 106.79 | 107.88 | 108.75 | 106.09 | 1.588 times |
14 Tue May 2024 | 105.46 | 109.53 | 111.02 | 105.27 | 1.219 times |
13 Mon May 2024 | 108.05 | 109.16 | 109.48 | 106.01 | 0.804 times |
10 Fri May 2024 | 106.70 | 108.71 | 109.02 | 106.01 | 0.852 times |
My analysis of stock is bearish for shortterm, and stock might move down till 98 or till 91.3. Use a stoploss of 103.5 and if the stock hits stoploss, then it can shoot up till 109.03
Share price targets for Blueprint Medicines (BPMC)
Target Type | Value |
Downside Target | 72.24 |
Downside Target | 75.20 |
Downside Target | 84.33 |
Downside Target | 86.52 |
Downside Target | 90.75 |
Downside Target | 93.07 |
Downside Target | 94.98 |
Downside Target | 97.00 |
Downside Target | 101.00 |
Upside Target | 103.23 |
Upside Target | 105.64 |
Upside Target | 109.87 |
Upside Target | 110.93 |
Upside Target | 111.02 |
Intraday share price targets for Blueprint Medicines (BPMC)
Target Type | Value |
Downside Intraday Target | 100.52 |
Downside Intraday Target | 98.65 |
Upside Intraday Target | 104.95 |
Upside Intraday Target | 107.51 |
Upside Intraday Target | 103.08 |
Weekly technical analysis of Blueprint Medicines (BPMC)
Date | Weekly Closing Price | Open | High | Low | Volume |
23 Thu May 2024 | 102.39 | 104.87 | 105.64 | 101.21 | 0.717 times |
17 Fri May 2024 | 104.96 | 109.16 | 111.02 | 103.23 | 0.848 times |
10 Fri May 2024 | 106.70 | 107.93 | 109.87 | 103.31 | 0.594 times |
03 Fri May 2024 | 107.19 | 93.52 | 110.93 | 90.75 | 1.382 times |
26 Fri Apr 2024 | 93.00 | 87.76 | 94.98 | 86.52 | 1.143 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Blueprint Medicines (BPMC)
Date | Monthly Closing Price | Open | High | Low | Volume |
23 Thu May 2024 | 102.39 | 91.44 | 111.02 | 90.85 | 0.831 times |
30 Tue Apr 2024 | 91.34 | 95.00 | 97.00 | 84.33 | 0.835 times |
28 Thu Mar 2024 | 94.86 | 93.81 | 98.06 | 84.81 | 0.82 times |
29 Thu Feb 2024 | 93.52 | 79.33 | 101.00 | 72.24 | 1.428 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Blueprint Medicines (BPMC)
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Blueprint Medicines stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Blueprint Medicines in short term but the sell signal is initial and weak.
Blueprint Medicines Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a buy signal for Blueprint Medicines in short term but BUY signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Blueprint Medicines is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 105.19 and Blueprint Medicines (BPMC) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Blueprint Medicines (BPMC) stock. Volume based technical analysis of Blueprint Medicines (BPMC) stock is negative.
Blueprint Medicines Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Blueprint Medicines stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Blueprint Medicines in short term but the sell signal is initial and weak.
Blueprint Medicines Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a buy signal for Blueprint Medicines in short term but BUY signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Blueprint Medicines is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 105.19 and Blueprint Medicines (BPMC) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Blueprint Medicines (BPMC) stock. Volume based technical analysis of Blueprint Medicines (BPMC) stock is negative.
Blueprint Medicines Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.